Oramed Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Oramed Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 50% to $1,340,000. The net income raised on $5,525,000 and profit margin reached 412%. Total operating expenses were $17,109,000.
Profit Margin
| 2014 | 0 | -5.69M | |
|---|---|---|---|
| 2015 | 0 | -7.23M | |
| 2016 | 641K | -10.96M | -1710.45% |
| 2017 | 2.45M | -10.48M | -426.71% |
| 2018 | 2.44M | -12.72M | -519.68% |
| 2019 | 2.70M | -14.35M | -531.08% |
| 2020 | 2.71M | -11.51M | -424.76% |
| 2021 | 2.70M | -22.23M | -822.72% |
| 2022 | 2.70M | -37.76M | -1397.11% |
| 2023 | 1.34M | 5.52M | 412.31% |
ORMP Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.34M | 2.70M | 2.70M | 2.71M | 2.70M | 2.44M | 2.45M | 641K | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 90K | 90K | 86K | 187K | 490K | 0 | 0 |
Gross profit | 1.34M | 2.70M | 2.70M | 2.62M | 2.61M | 2.36M | 2.26M | 151K | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 8.97M | 27.63M | 20.98M | 10.23M | 13.52M | 11.97M | 10.28M | 7.70M | 4.78M | 3.27M |
Selling and marketing | -287K | 1.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 17.10M | 43.30M | 26.92M | 14.46M | 17.24M | 16.06M | 13.04M | 10.16M | 7.38M | 5.90M |
Operating income | -15.76M | -40.59M | -24.22M | -11.75M | -14.63M | -13.52M | -10.77M | -10.01M | -7.38M | -5.90M |
Other income (expenses), net | 20.85M | 2.93M | 893K | -438K | -450K | -30K | -10K | -17K | -3K | 214K |
Income before tax | 5.08M | -37.66M | -22.98M | -11.51M | -14.05M | -12.72M | -10.08M | -9.62M | -7.23M | -5.69M |
Income tax expense | 0 | 100K | -2.87M | 192K | 300K | -800K | 400K | 1.33M | -1K | 4K |
Net income | 5.52M | -37.76M | -22.23M | -11.51M | -14.35M | -12.72M | -10.48M | -10.96M | -7.23M | -5.69M |
Earnings per share | ||||||||||
Basic EPS | 0.14 | -0.97 | -0.78 | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 | -0.67 | -0.62 |
Diluted EPS | 0.14 | -0.97 | -0.78 | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 | -0.67 | -0.62 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |